Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 4 | 2023 | 1803 | 1.080 |
Why?
|
| Child Development | 3 | 2022 | 260 | 0.850 |
Why?
|
| NADPH Oxidases | 4 | 2009 | 114 | 0.650 |
Why?
|
| Health Information Systems | 1 | 2019 | 32 | 0.620 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2022 | 1098 | 0.600 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 377 | 0.600 |
Why?
|
| Developmental Disabilities | 2 | 2019 | 704 | 0.570 |
Why?
|
| Hippocampus | 6 | 2009 | 819 | 0.540 |
Why?
|
| Referral and Consultation | 1 | 2019 | 528 | 0.490 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 615 | 0.480 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 2 | 2009 | 41 | 0.400 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2009 | 344 | 0.350 |
Why?
|
| Synapses | 4 | 2008 | 447 | 0.340 |
Why?
|
| Organ Culture Techniques | 2 | 2009 | 154 | 0.340 |
Why?
|
| Risk Assessment | 1 | 2019 | 3341 | 0.340 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 143 | 0.320 |
Why?
|
| Heart Arrest, Induced | 1 | 2009 | 73 | 0.310 |
Why?
|
| Hyperglycemia | 1 | 2010 | 222 | 0.310 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2009 | 77 | 0.300 |
Why?
|
| Manganese | 1 | 2008 | 48 | 0.300 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 204 | 0.290 |
Why?
|
| Axons | 1 | 2010 | 380 | 0.290 |
Why?
|
| Reactive Oxygen Species | 2 | 2010 | 483 | 0.260 |
Why?
|
| Cerebrovascular Circulation | 1 | 2009 | 430 | 0.260 |
Why?
|
| Oxidative Stress | 2 | 2010 | 796 | 0.260 |
Why?
|
| Neuronal Plasticity | 2 | 2006 | 273 | 0.250 |
Why?
|
| Brain | 2 | 2009 | 2964 | 0.240 |
Why?
|
| Nervous System Diseases | 1 | 2008 | 375 | 0.230 |
Why?
|
| Superoxides | 2 | 2005 | 154 | 0.230 |
Why?
|
| Risk Factors | 4 | 2023 | 10033 | 0.230 |
Why?
|
| Energy Metabolism | 1 | 2009 | 774 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2010 | 3553 | 0.210 |
Why?
|
| Infant | 4 | 2023 | 12370 | 0.210 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2002 | 1 | 0.210 |
Why?
|
| Connective Tissue Diseases | 1 | 2023 | 29 | 0.210 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 187 | 0.200 |
Why?
|
| Aging | 2 | 2006 | 1185 | 0.180 |
Why?
|
| Retrospective Studies | 4 | 2023 | 16081 | 0.180 |
Why?
|
| Microdialysis | 2 | 2009 | 56 | 0.160 |
Why?
|
| Genetic Vectors | 1 | 2002 | 939 | 0.160 |
Why?
|
| Nervous System | 1 | 2019 | 127 | 0.160 |
Why?
|
| Lactic Acid | 2 | 2009 | 147 | 0.160 |
Why?
|
| Animals | 13 | 2010 | 33850 | 0.150 |
Why?
|
| Oxygen Consumption | 2 | 2009 | 307 | 0.150 |
Why?
|
| Seizures | 1 | 2023 | 875 | 0.150 |
Why?
|
| Child Behavior | 1 | 2019 | 233 | 0.140 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 251 | 0.140 |
Why?
|
| Postoperative Care | 1 | 2019 | 294 | 0.140 |
Why?
|
| Male | 11 | 2023 | 60345 | 0.130 |
Why?
|
| Child | 3 | 2023 | 24262 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2009 | 1218 | 0.110 |
Why?
|
| Incidence | 1 | 2019 | 3055 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 5 | 2008 | 4360 | 0.090 |
Why?
|
| Mice | 8 | 2010 | 17555 | 0.090 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2010 | 21 | 0.090 |
Why?
|
| Texas | 1 | 2019 | 3558 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2023 | 13927 | 0.080 |
Why?
|
| Onium Compounds | 1 | 2009 | 4 | 0.080 |
Why?
|
| Aconitine | 1 | 2009 | 9 | 0.080 |
Why?
|
| Acetophenones | 1 | 2009 | 12 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5061 | 0.080 |
Why?
|
| Rats | 2 | 2009 | 3668 | 0.080 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2009 | 57 | 0.080 |
Why?
|
| DNA Primers | 1 | 2010 | 659 | 0.080 |
Why?
|
| Humans | 7 | 2023 | 123280 | 0.080 |
Why?
|
| Intraoperative Period | 1 | 2009 | 73 | 0.080 |
Why?
|
| Glycerol | 1 | 2009 | 91 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8116 | 0.080 |
Why?
|
| Sus scrofa | 1 | 2009 | 125 | 0.080 |
Why?
|
| Body Temperature | 1 | 2009 | 113 | 0.080 |
Why?
|
| Probability | 1 | 2009 | 321 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 1 | 2009 | 128 | 0.080 |
Why?
|
| Receptors, Nicotinic | 1 | 2009 | 154 | 0.080 |
Why?
|
| Memantine | 1 | 2008 | 17 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 392 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 424 | 0.080 |
Why?
|
| Random Allocation | 1 | 2009 | 433 | 0.080 |
Why?
|
| Perfusion | 1 | 2009 | 200 | 0.080 |
Why?
|
| Nicotine | 1 | 2009 | 141 | 0.080 |
Why?
|
| Isoflurane | 1 | 2008 | 45 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2009 | 619 | 0.080 |
Why?
|
| Female | 4 | 2023 | 65628 | 0.070 |
Why?
|
| Brain Mapping | 1 | 2010 | 396 | 0.070 |
Why?
|
| Gene Expression | 2 | 2010 | 1566 | 0.070 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 29 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2005 | 1686 | 0.070 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2006 | 25 | 0.070 |
Why?
|
| Contrast Media | 1 | 2010 | 471 | 0.060 |
Why?
|
| Base Sequence | 1 | 2010 | 3090 | 0.060 |
Why?
|
| Swine | 1 | 2009 | 1167 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2009 | 1002 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 1238 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 1414 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 139 | 0.060 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2005 | 32 | 0.060 |
Why?
|
| Time Factors | 2 | 2019 | 6223 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 258 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 148 | 0.060 |
Why?
|
| Protein Transport | 1 | 2006 | 367 | 0.060 |
Why?
|
| Survival Rate | 1 | 2009 | 2005 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 2019 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2006 | 458 | 0.060 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 118 | 0.060 |
Why?
|
| Long-Term Potentiation | 1 | 2005 | 163 | 0.050 |
Why?
|
| Hypoxia | 1 | 2005 | 248 | 0.050 |
Why?
|
| Corpus Striatum | 1 | 2003 | 89 | 0.050 |
Why?
|
| Pseudorabies | 1 | 2002 | 1 | 0.050 |
Why?
|
| Amygdala | 1 | 2003 | 81 | 0.050 |
Why?
|
| Thalamus | 1 | 2003 | 85 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2002 | 29 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 95 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2002 | 225 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 4299 | 0.050 |
Why?
|
| Monocytes | 1 | 2002 | 345 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2003 | 448 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2008 | 3734 | 0.040 |
Why?
|
| Virus Replication | 1 | 2002 | 602 | 0.040 |
Why?
|
| Language Development | 1 | 2019 | 32 | 0.040 |
Why?
|
| Macrophages | 1 | 2002 | 604 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 947 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2009 | 3019 | 0.040 |
Why?
|
| Motor Activity | 1 | 2019 | 522 | 0.030 |
Why?
|
| Cognition | 1 | 2019 | 736 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3384 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 2808 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2010 | 166 | 0.020 |
Why?
|
| United States | 1 | 2023 | 10655 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 577 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2006 | 130 | 0.020 |
Why?
|
| NADPH Oxidase 2 | 1 | 2005 | 40 | 0.020 |
Why?
|
| Prosencephalon | 1 | 2005 | 40 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2006 | 383 | 0.020 |
Why?
|
| Phorbol Esters | 1 | 2005 | 22 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 98 | 0.020 |
Why?
|
| Cytosol | 1 | 2005 | 158 | 0.010 |
Why?
|
| Biological Transport | 1 | 2005 | 346 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 12176 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 412 | 0.010 |
Why?
|
| Learning | 1 | 2006 | 361 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 2398 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 3045 | 0.010 |
Why?
|